Bristol Myers Squibb · Pharmaceuticals & biotech
AI across biologics and cell-therapy production at BMS Devens
a 42% reduction in New Product Introduction (NPI) time
Case study · Pharmaceuticals & biotech
Pfizer wanted more consistent batches, higher yield and shorter cycle times across a network of 30+ manufacturing sites.
Manufacturer-reported This result comes from the manufacturer's own publications, such as newsroom posts, earnings materials or engineering blogs. It has not been independently verified.
Pfizer wanted more consistent batches, higher yield and shorter cycle times across a network of 30+ manufacturing sites.
Pfizer identifies the optimal process parameters for each product (the Golden Batch), then uses AI to detect anomalies and recommend real-time actions to operators, coordinated through its Digital Operations Center.
Percent change as reported by the source; hover for the exact wording
AI compares live production to Golden Batch parameters, flags anomalies and recommends real-time operator actions.
Outcomes as reported by the source. We do not adjust, combine or extrapolate reported figures.
Bristol Myers Squibb · Pharmaceuticals & biotech
a 42% reduction in New Product Introduction (NPI) time
Argos USA · Cement, glass & building materials
Demonstrated 28% reduction in energy consumption while maintaining product quality and improving throughput at the cement plant.
Georgia-Pacific · Paper & packaging
Demonstrated 40% reduction in defoamer usage, improving environmental impact of brownstock washing.
Novelis · Metals & fabrication
53% Scope 3 emissions
Put AI to work
Genvo, our implementation partner, works with manufacturers to pick the right first project, connect the systems you already run and put AI agents and tools into daily use, with people approving what goes out.
Assessments and consultations are provided by Genvo. How our partnership works.